It's not just a problem with antivirals. The same groups are also disproportionately missing out on COVIDvaccination, compounding their risk of severe illness. The pattern is repeated for other important preventive health care, such ascancerscreening. A 3-step plan to meet patients' needs The ...
Australia finally permitted in July 2022 the use of oral antivirals against COVID-19. For the previous 2.5 years, the local bureaucrats have prevented medical doctors to prescribe the antivirals successfully used in other jurisdictions. Suddenly, they changed their mind, even if the opening of ...
As their efficacy and safety are under investigation, none of the regulatory agencies approved them for the treatment of COVID infection. Although chloroquine and hydroxychloroquine possess antiviral and immunomodulatory effects, in practice benefit of their use for COVID treatment is controversial. ...
Introduction: Coronavirus Disease 2019 is a contagious infection which has infected millions worldwide. The objective of this systematic review is to identify studies pertaining to antivirals, both as sole and combined therapies, in COVID-19 patients and review the clinical outcomes of these ...
This study identifies a promising preclinical candidate for the treatment of Dengue virus infection. Katie Kingwell Research Highlights01 Mar 2021Nature Reviews Microbiology Volume: 19, P: 221 COVID-19 therapies and vaccine landscape Within a few weeks of the novel coronavirus genome sequence being pu...
The FDA's decision has added another at-home COVID-19 treatment option to help keep high-risk people out of the hospital. Merck's pill, called molnupiravir, is authorized to use in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progressio...
Single shot of peginterferon-lambda accelerates clearance of COVID-19 infection, UHN-led study shows. Credit: Courtesy UHN UHN-led study indicates peginterferon-lambda treatment can speed up clearance of the coronavirus in non-hospitalized patients, with potential to improve clinical outcomes and curb...
Vaccines are generally only effective when administered prior to infection, butantiviral agentsare important because they can treat people who already have COVID-19. Here's an overview ofantiviral drugsscientists are investigating forcoronavirus. ...
Vaccines are generally only effective when administered prior to infection, butantiviral agentsare important because they can treat people who already have COVID-19. Here's an overview ofantiviral drugsscientists are investigating forcoronavirus. ...
vaccine and authorized others to prevent COVID-19 and serious clinical outcomes associated with a COVID-19 infection, including hospitalization and death. The FDA urges the public to get vaccinated and receive a booster if eligible. Learn more about FDA-approved or -authorized COVID-19 vaccines....